– FOPD, a brand that is creating paradigm shifts in the 2nd medical opinion market and Indian Healthcare industry
Mumbai ,January 2020: For the very first time in India, FOREIGN OPD ™ -India’s first and only medical healthcare brand that enables face2face™ second medical opinion consultations brings Dr. Simon Taylor, Consultant Hepatologist from Imperial College London, to India. In a scenario where the Indian Healthcare industry is evolving rapidly and more & more patients are demanding worldclass expertise and experience, this is a milestone achieved where a top level medical expert is coming down to India to cater to the growing demand of patients, that too at an affordable price. Speaking on the occasion Dr Inder Maurya, Founder & CEO said, “We are happy to bring Dr. Simon Taylor an eminent faculty from the Imperial College, London, to India. Our country is poised to avail of these kind of service level innovations in Healthcare. Foreign OPD sees that the best of the best and world class 2nd medical opinion can be made available to patients suffering from chronic diseases and are unable to fly to International shores to seek such consultation if they discern. It is a paradigm shift in terms of how Healthcare is consumed in India and we are proud to assume a pioneering role”.
Currently catering to 25000 patients through pan-India reach, Foreign OPD™ has 100+ international consultantsonboard from the best of the global fraternity along with a stellar list of 150+ Indian doctors as well. The current therapeutic areas covered are – Hepatology, Oncology, CVTS, Organ Transplant, Neurology. and plans to expand to over 25 sub-specialties, going forward. Talking to the press, Dr. Simon Taylor, Consultant Hepatologist, Imperial College Healthcare NHS Trust, London, UK said, “I am extremely happy to come to India and associate with Foreign OPD. The Medical & Healthcare sector is extremely professional in India and there are several innovative leaps that the country has taken in this direction which makes them on a par with global best practices. World over, the 2nd medical opinion is a pressing need, given the increasing complexity of modern medicine and these are concrete steps being taken in that direction”. He further added, “In UK / EU for Hepatalogy, the fraternity that I belong to, there are regional liver units and a network of hospitals sending patients for 2nd opinions and they operate in a hub & spoke model. A formal second medical opinion is actually mandatory before treatment! I am happy to have engaged with Foreign OPD, who has also provided me with a platform to engage with my fellow colleagues for a fair exchange of knowledge as well”
The global Medical Second Opinion market was valued at $2.7 billion in 2018. It is expected to reach $7.10 billion by end-2024, growing at a compounded annual growth rate (CAGR) of 28 per cent. China and India are among the fastest-growing regions in Medical Second Opinion market. Discerning Indian patients are now keen to try out expert global consultations too and also seek expert counselling from experts in India. The company has a dedicated team that looks into the doctors’ experience, research & publications and areas of specialisation. The brand is in an expansion spree. Currently operational in Mumbai, Delhi, Lucknow and Bengaluru, it is looking at expanding to 30 cities while covering 70,000 patients
About Foreign OPD: FOREIGN OPD ™ is India’s only first and only healthcare brand that enables face2face™ second medical opinion consultations with international medical experts in India. At FOREIGN OPD ™ we are disrupting the second opinion market in India by collaborating with leading medical experts in UK & USA across 25 clinical sub-specialties including Oncology, Cardiology and Neurology. Having the cutting edge USP of collaborating, arranging, expediting, face2face™ second opinions from well-known international medical facilities and professionals while also aiming at having a panel of 1000 + domestic doctors, the brand is pitted at becoming the largest networked service provider in the Indian market place.